Constitutive expression of IL-6-like cytokines in normal bone marrow: Implications for pathophysiology of myeloma

Cytokine

Volumn 12, Issue 10, 2000, Pages 1537-1545

  Barton, Beverly E ^a   Murphy, Thomas F ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Bone marrow; IL 6; Myeloma

Indexed keywords

CYTOKINE; DEXAMETHASONE; GROWTH FACTOR; INTERLEUKIN 6;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW; BONE MARROW CELL; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HUMAN; HUMAN CELL; LYMPHOCYTE HOMING; MALE; MOUSE; MYELOMA; MYELOMA CELL; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; SPLEEN CELL; STROMA CELL;

ANIMALIA;

EID: 0033790472     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.2000.0748     Document Type: Article

References (51)

1. Total therapy with tandem transplants for newly diagnosed multiple myeloma
2. Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflection of disease severity in plasma cell dyscrasias
3. Interleukin-6 is the central tumor growth factor in vitro and in vivo in multiple myeloma
4. Interleukin-6 prevents dexamethasone-induced myeloma cell death
5. Interleukin-6 negates the cytotoxicity of dexamethasone in myeloma
6. Establishment and characterization of a human stroma-dependent myeloma cell line (MM5.1) and its stroma-independent variant
7. Ciliary neurotrophic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp130
8. Oncostatin M, leukemia inhibitory factor, and interleukin 6 induce the proliferation of human plasmacytoma cells via the common signal transducer, gp130
9. A ciliary neurotrophic factor-sensitive human myeloma cell line
10. Oncostatin M stimulates proliferation in B9 hybridoma cells: Potential role of oncostatin M in plasmacytoma development
11. Growth regulatory pathways in myeloma. Evidence for autocrine oncostatin M expression
12. Interleukin-10 is a growth factor for human myeloma cells by induction of an oncostatin M autocrine loop
13. The gp130 family cytokines IL-6, LIF and OSM but not IL-11 can reverse the anti-proliferative effect of dexamethasone on human myeloma cells
14. Biologic effects of anti-interleukin-6 murine monoclonal antibody in advanced multiple myeloma
15. Murine antiinterleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia
16. Biology and treatment of multiple myeloma
17. Multiple myeloma
18. Adhesion of human myeloma-derived cell lines to bone marrow stromal cells stimulates interleukin-6 secretion
19. Adhesion of multiple myeloma cells to the bone marrow microenvironment: Implications for future therapeutic strategies
20. The development of a model for the homing of multiple myeloma cells to human bone marrow
21. Adhesion of multiple myeloma cells to the bone marrow microenvironment: Implications for future therapeutic strategies
22. The bone marrow stromal environment is a major factor in myeloma cell resistance to dexamethasone
23. Human CD34+ bone marrow cells regulate stromal production of interleukin-6 and granulocyte colony-stimulating factor and increase the colony-stimulating activity of stroma
24. In vivo interleukin 6 gene expression in the tumoral environment in multiple myeloma
25. Long-term bone marrow cultures stromal cells regulate myeloma tumour growth in vitro: Studies with primary tumour cells and LTBMC-dependent cell lines
26. The pivotal role of interleukin 6 in formation and function of hematopoietically active murine long-term bone marrow cultures
27. A model that reproduces syndromes associated with human multiple myeloma in nonirradiated SCID mice
28. Interleukin-6 gene expression in multiple myeloma: A characteristic of immature tumor cells
29. Macrophage-derived factor required by plasmacytomas for survival and proliferation in vitro
30. Regulation of IL-6 expression by oncostatin M
31. Oncostatin M binds the high-affinity leukemia inhibitory factor receptor
32. The IL-6 signal transducer, gp130: An oncostatin M receptor and affinity converter for the LIF receptor
33. Differential sensitivity of human myeloma cell lines and normal bone marrow colony forming cells to a recombinant diphtheria toxin-interleukin 6 fusion protein
34. The 5T2 mouse multiple myeloma model: Characterization of 5T2 cells within the bone marrow
35. Detection of interleukin-6 (IL-6) in human bone marrow myeloma cells by light and electron microscopy
36. Establishment of two interleukin 6 (B cell stimulatory factor 2/interferon β2)-dependent human bone marrow-derived myeloma cell lines
37. Interleukin-10 is a proliferation factor, but not a differentiation factor for human myeloma cells
38. Serum interleukin 10 in early stage multiple myeloma
39. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes
40. Cytokine receptor expression on hematopoietic stem and progenitor cells
41. AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6
42. Oncostatin M as a potent mitogen for AIDS-Kaposi's sarcoma-derived cells
43. Interleukin 3 induces the differentiation of bone marrow precursor cells to osteoclast-like cells
44. Increased osteoclast development after estrogen loss: Mediation by interleukin-6
45. IL-6 stimulates osteoclast-like multinucleated cell formation in long term human bone marrow cultures by inducing IL-1 release
46. The role of gp130-mediated signals in osteoclast development: Regulation of interleukin 11 production by osteoblasts and distribution of its receptor in bone marrow cultures
47. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6
48. Interleukin (IL)-6 induction of osteoclast differentiation depend on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors
49. Interleukin-6 does not stimulate bone resorption in neonatal mouse calvariae
50. Membrane proteins of living mammalian cells as studied by enzymatic hydrolysis of fluorogenic esters
51. Primary myeloma cells growing in SCID-hu mice: A model for studying the biology and treatment of myeloma and its manifestations